{"id":"https://openalex.org/W3099856405","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","title":"774 Antibiotic administration prior to immunotherapy leads to poor overall survival across multiple malignancies","display_name":"774 Antibiotic administration prior to immunotherapy leads to poor overall survival across multiple malignancies","publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3099856405","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","mag":"3099856405"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2020-sitc2020.0774","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","pdf_url":"https://jitc.bmj.com/content/jitc/8/Suppl_3/A464.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-breaking abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/8/Suppl_3/A464.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056138209","display_name":"Eric J. Vick","orcid":"https://orcid.org/0000-0002-8754-8049","observed_orcids":["https://orcid.org/0000-0002-8754-8049"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Vick","raw_affiliation_strings":["University of Cincinnati Cancer Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Cancer Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060157230","display_name":"Inas A. Abuali","orcid":"https://orcid.org/0000-0001-9134-9483","observed_orcids":["https://orcid.org/0000-0001-9134-9483"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Inas Abuali","raw_affiliation_strings":["University of Cincinnati Cancer Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Cancer Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013066781","display_name":"Sarah Ludvigsen","orcid":"https://orcid.org/0009-0007-6207-0660","observed_orcids":["https://orcid.org/0009-0007-6207-0660"]},"institutions":[{"id":"https://openalex.org/I92156820","display_name":"University of Cincinnati Medical Center","ror":"https://ror.org/02p72h367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I92156820"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah Ludvigsen","raw_affiliation_strings":["University of Cincinnati Medical Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Medical Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I92156820"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048130986","display_name":"Andrew C. Kelleher","orcid":"https://orcid.org/0000-0002-0377-3207","observed_orcids":["https://orcid.org/0000-0002-0377-3207"]},"institutions":[{"id":"https://openalex.org/I92156820","display_name":"University of Cincinnati Medical Center","ror":"https://ror.org/02p72h367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I92156820"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Kelleher","raw_affiliation_strings":["University of Cincinnati Medical Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Medical Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I92156820"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042793052","display_name":"Nathanael D. Moore","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I92156820","display_name":"University of Cincinnati Medical Center","ror":"https://ror.org/02p72h367","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I92156820"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathanael Moore","raw_affiliation_strings":["University of Cincinnati Medical Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Medical Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I92156820"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059964504","display_name":"Nicholas Arias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nicholas Arias","raw_affiliation_strings":["University of Cincinnati, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050155318","display_name":"Shuchi Gulati","orcid":"https://orcid.org/0000-0001-6793-9694","observed_orcids":["https://orcid.org/0000-0001-6793-9694"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuchi Gulati","raw_affiliation_strings":["University of Cincinnati Cancer Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Cancer Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061224094","display_name":"Trisha Michel Wise-Draper","orcid":"https://orcid.org/0000-0002-7279-4028","observed_orcids":["https://orcid.org/0000-0002-7279-4028"]},"institutions":[{"id":"https://openalex.org/I63135867","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079","country_code":"US","type":"education","lineage":["https://openalex.org/I63135867"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Trisha Wise-Draper","raw_affiliation_strings":["University of Cincinnati Cancer Center, Cincinnati, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Cincinnati Cancer Center, Cincinnati, OH, USA","institution_ids":["https://openalex.org/I63135867"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":0.5156,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.81831832,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":"A464","last_page":"A465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/antibiotic-use","display_name":"antibiotic use","score":0.5740000009536743},{"id":"https://openalex.org/keywords/prior-antibiotic-use","display_name":"prior antibiotic use","score":0.6380000114440918},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.8349999785423279},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.8849999904632568},{"id":"https://openalex.org/keywords/gut-microbiota","display_name":"gut microbiota","score":0.5519999861717224},{"id":"https://openalex.org/keywords/immunotherapy-efficacy","display_name":"immunotherapy efficacy","score":0.6710000038146973},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.8330000042915344},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/renal-cell-carcinoma","display_name":"renal cell carcinoma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.8379999995231628},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":0.8790000081062317},{"id":"https://openalex.org/keywords/durvalumab","display_name":"durvalumab","score":0.8709999918937683},{"id":"https://openalex.org/keywords/cancer-immunotherapy-outcomes","display_name":"cancer immunotherapy outcomes","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.779911994934082},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.731945276260376},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6247351765632629},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5917361378669739},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5420809984207153},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.4936457872390747},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.47475913166999817},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4633494019508362},{"id":"https://openalex.org/C195910791","wikidata":"https://www.wikidata.org/wiki/Q1324077","display_name":"Medical record","level":2,"score":0.4548535645008087},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4448601007461548},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.09150782227516174},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08569738268852234},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2020-sitc2020.0774","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","pdf_url":"https://jitc.bmj.com/content/jitc/8/Suppl_3/A464.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-breaking abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:93324093cd2e47a5a7b2cf92eee016b8","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/93324093cd2e47a5a7b2cf92eee016b8","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2020-sitc2020.0774","doi":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2020-sitc2020.0774","pdf_url":"https://jitc.bmj.com/content/jitc/8/Suppl_3/A464.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Late-breaking abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320310256","display_name":"University of Cincinnati","ror":"https://ror.org/01e3m7079"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3099856405.pdf","grobid_xml":"https://content.openalex.org/works/W3099856405.grobid-xml"},"referenced_works_count":6,"referenced_works":["https://openalex.org/W2018137967","https://openalex.org/W2784751095","https://openalex.org/W2808003286","https://openalex.org/W2899142076","https://openalex.org/W3098126368","https://openalex.org/W3105210602"],"related_works":["https://openalex.org/W6958304166","https://openalex.org/W3011314376","https://openalex.org/W4391383613","https://openalex.org/W3120296211","https://openalex.org/W2961510294","https://openalex.org/W4322767412","https://openalex.org/W2994690197","https://openalex.org/W3137283383","https://openalex.org/W2987253676","https://openalex.org/W4311747000"],"abstract_inverted_index":{"Background":[0],"The":[1,123,204,263,481],"use":[2,51,156,356,360,382],"of":[3,20,48,77,79,108,132,139,152,260,278,285,378,383,410,413,418,421,424,429,483,487,525,583,619],"immune":[4,497,531,552,592],"checkpoint":[5,287,498,532,553,593],"inhibitors":[6],"(ICI)":[7],"has":[8,35],"increased":[9,28],"significantly":[10],"in":[11,30,45,63,81,492,556,596],"the":[12,18,46,106,109,130,137,147,258,292,375,381,402,408,422,427],"past":[13],"five":[14],"years,":[15,330,339],"along":[16],"with":[17,59,65,159,304,496,521,530,559,587,598],"number":[19],"available":[21],"drugs":[22],"and":[23,53,70,141,150,162,172,182,190,218,245,249,274,301,309,345,361,393,415,426,458,589],"regimens.":[24],"ICIs":[25,80,140,266],"have":[26,42,89],"dramatically":[27],"survival":[29,191,308,311,524,588],"cancer":[31,168,230,236,239,242,563],"patients,":[32],"however,":[33,86],"there":[34],"been":[36],"data":[37,261,372],"to":[38,98,196,322,358,374,386,390,400,591],"show":[39],"that":[40,91,105,380],"they":[41],"reduced":[43],"efficacy":[44,114],"presence":[47],"antibiotics.1":[49],"Antibiotic":[50,456],"prior":[52,321,357,385,584],"during":[54],"ICI":[55,113,155,256,323,359,365,387],"therapy":[56,324,457,595],"was":[57,127,144,193,207,312],"associated":[58,520],"worsening":[60],"clinical":[61,173],"outcomes":[62],"patients":[64,201,277,494,528,558,597],"renal":[66,238,489],"cell":[67,228,234,490,561],"carcinoma,2":[68],"melanoma,3":[69],"non-small-cell-lung-cancer.4":[71],"Specifically,":[72],"exposure":[73],"within":[74,282],"60":[75],"days":[76],"initiation":[78],"NSCLC":[82],"seemed":[83],"most":[84,264,293],"detrimental,":[85],"some":[87],"studies":[88],"suggested":[90],"antibiotics":[92,153,281,290,320,384,484,620],"disrupt":[93],"intestinal":[94],"microflora":[95],"for":[96,118,136,314,433],"up":[97],"six":[99],"months.5":[100],"6":[101,283],"Therefore,":[102],"we":[103],"hypothesized":[104],"duration":[107,151],"antibiotic":[110,177,355,585],"effect":[111,618],"on":[112,146,255,485,621],"may":[115],"be":[116],"present":[117],"a":[119],"longer":[120],"duration.":[121],"Methods":[122],"electronic":[124],"medical":[125],"record":[126],"queried":[128],"at":[129,257],"University":[131,409,423,428],"Cincinnati":[133,411,430],"Medical":[134,431],"Center":[135,432],"administration":[138,158],"antibiotics.":[142],"Data":[143],"collected":[145],"use,":[148],"type,":[149,167,169,366],"before":[154],"after":[157],"relevant":[160],"demographic":[161],"clinicopathologic":[163],"variables":[164],"including":[165,175],"treatment":[166,388,586],"staging":[170],"information,":[171],"course":[174],"subsequent":[176],"use.":[178],"Univariant":[179],"(Fischer\u2019s":[180],"Exact)":[181],"multivariant":[183],"analysis":[184,192],"(multiple":[185],"logistic":[186],"regression)":[187],"were":[188,202,212,220,267,296],"conducted":[189],"determined":[194],"according":[195],"log-rank":[197],"testing.":[198],"Results":[199],"217":[200],"examined.":[203],"median":[205,334],"age":[206],"64":[208],"(range":[209],"22-93),":[210],"38%":[211],"female,":[213],"73%":[214],"had":[215],"ECOG":[216,368],"0-1,":[217],"77%":[219],"white.":[221],"Cancer":[222,406,465,566],"types":[223],"included":[224],"melanoma":[225,527],"24%,":[226],"non-small":[227,560],"lung":[229,235,562],"(NSCLC)":[231],"34%,":[232],"small":[233],"2%,":[237],"11%,":[240,248],"urothelial":[241],"10%,":[243],"head":[244],"neck":[246],"cancers":[247],"16%":[250],"other":[251],"primaries.":[252],"20%":[253],"remained":[254],"time":[259],"entry.":[262],"common":[265,294],"pembrolizumab,":[268],"nivolumab,":[269],"followed":[270],"by":[271],"ipilimumab-nivolumab,":[272],"ipilimumab,":[273],"durvalumab.":[275],"81":[276],"218":[279],"received":[280],"months":[284],"receiving":[286],"inhibitors.":[288,462,499,533],"Of":[289],"administered,":[291],"classes":[295],"cephalosporins":[297],"(86%),":[298],"fluoroquinolones":[299],"(28%),":[300],"glycopeptides":[302],"(23%)":[303],"substantial":[305],"overlap.":[306],"Overall":[307],"progression-free":[310,394,523],"improved":[313],"those":[315],"who":[316],"did":[317],"not":[318],"receive":[319],"(median":[325],"OS":[326],"6.5":[327],"vs.":[328],"2.3":[329],"HR":[331,340],"0.36,":[332],"p<0.0001;":[333],"PFS":[335],"1.1":[336],"vs":[337],"0.5":[338],"0.6,":[341],"p=0.0027)":[342],"(figure":[343],"1":[344],"2":[346],"respectively).":[347],"Linear":[348],"regression":[349],"showed":[350],"no":[351],"significant":[352],"association":[353],"between":[354],"age,":[362],"sex,":[363],"race,":[364],"or":[367],"status.":[369],"Conclusions":[370],"This":[371],"adds":[373],"growing":[376],"body":[377],"knowledge":[379],"leads":[389],"inferior":[391],"overall":[392],"survival.":[395],"Acknowledgements":[396],"We":[397],"would":[398],"like":[399],"thank":[401],"Roman":[403],"Jandarov,":[404],"UC":[405],"Center,":[407],"Division":[412],"Hematology":[414],"Oncology,":[416],"Department":[417],"Internal":[419],"Medicine":[420],"Cincinnati,":[425],"their":[434],"continued":[435],"support.":[436],"Ethics":[437],"Approval":[438],"IRB":[439],"2019-0610":[440],"References":[441],"Pinato":[442,568],"DJ,":[443,569],"Gramenitskaya":[444],"D,":[445,573],"Altmann":[446],"DM,":[447],"Boyton":[448],"RJ,":[449],"Mullish":[450],"BH,":[451],"Marchesi":[452],"JR,":[453],"et":[454,479,516,548,580,615],"al.":[455,480,517,549,581,616],"outcome":[459],"from":[460],"immune-checkpoint":[461],"J":[463],"Immunother":[464],"2019;7:287.":[466],"Ueda":[467],"K,":[468],"Yonekura":[469],"S,":[470,571,604],"Ogasawara":[471],"N,":[472],"Matsunaga":[473],"Y,":[474],"Hoshino":[475],"R,":[476],"Kurose":[477],"H,":[478,575],"impact":[482],"prognosis":[486],"metastatic":[488],"carcinoma":[491],"japanese":[493],"treated":[495,529],"Anticancer":[500],"Res":[501],"2019;39:6265\u201371.":[502],"Elkrief":[503],"A,":[504,537,577,614],"El":[505],"Raichani":[506],"L,":[507,543,545],"Richard":[508],"C,":[509,547],"Messaoudene":[510],"M,":[511],"Belkaid":[512],"W,":[513],"Malo":[514],"J,":[515],"Antibiotics":[518,550],"are":[519],"decreased":[522],"advanced":[526],"Oncoimmunology":[534],"2019;8:e1568812.":[535],"Ruiz-Pati\u00f1o":[536],"Barr\u00f3n":[538],"F,":[539,608],"Cardona":[540],"AF,":[541],"Corrales":[542],"Mas":[544],"Mart\u00edn":[546],"impair":[551],"inhibitor":[554,594],"effectiveness":[555],"Hispanic":[557],"(AB-CLICaP).":[564],"Thorac":[565],"2020;(9):2552-2560.":[567],"Howlett":[570],"Ottaviani":[572],"Urus":[574],"Patel":[576],"Mineo":[578],"T,":[579],"Association":[582],"response":[590],"cancer.":[599],"JAMA":[600],"Oncol":[601],"2019;5(12):1774-1778.":[602],"Panda":[603],"Khader":[605],"IE,":[606],"Casellas":[607],"Vivancos":[609],"JL,":[610],"Cors":[611],"MG,":[612],"Santiago":[613],"Short-term":[617],"human":[622],"gut":[623],"microbiota.":[624],"PLoS":[625],"ONE":[626],"2014;9.":[627]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2020-11-23T00:00:00"}